This week in Pharmaceutical policy under President Trump

Tariffs on pharmaceuticals. First, President Trump has voiced his goal to impose tariffs on pharmaceutical products made overseas. The New York Times reports: Mr. Trump said in remarks to reporters on Monday that pharmaceutical tariffs would come in the “not too distant future.”“We don’t make our own drugs anymore,” Mr. Trump said. “The drug companies…

Read More

How Did We End Up with a Broken Health Insurance System? 

By LEONARD D’ AVOLIO The murder of UnitedHealthcare CEO Brian Thompson has drawn attention to Americans’ frustration with the for profit healthcare insurance industry. Change is possible but less likely if people don’t understand how we got here, the real issues, and how they might be fixed.  Health insurance wasn’t always run by big for…

Read More

Inestabilidad de la planta profesional en los CDC altera proyectos de VIH y desperdicia dinero, dicen investigadores

Decenas de expertos en VIH de los Centros para el Control y Prevención de Enfermedades (CDC) recibieron correos electrónicos el miércoles 11 de junio revocando las notificaciones de despido recibidas diez semanas atrás. Sin embargo, el daño a sus proyectos podría ser permanente, y las restricciones continuas a sus investigaciones perjudicarán vidas, dijeron científicos de…

Read More

Merchants of Death

That is the clever title of recent American Economic Review publication by Cyrus Aghamolla, Pinar Karaca-Mandic, Xuelin Li, Richard T. Thakor. The abstract is below. This study examines the link between credit supply and hospital health outcomes. We use bank stress tests as exogenous shocks to credit access for hospitals that have lending relationships with…

Read More